Carbapenem Market Key Players Analysis 2031
Carbapenems are a class of highly effective antibiotic agents which are commonly recommended for the treatment of severe or high-risk bacterial infections. Due to antibiotic properties, Carbapenems play a major role in the treatment of infectious diseases. The drug is used to treat frequently observed medical conditions such as aspiration pneumonia, bacteremia, bacterial infection, bone infection, bronchitis, and deep neck infection.
MARKET DYNAMICS
Increasing prevalence of bacterial infections is likely to drive the growth of global Carbapenem Market during the forecast period. However, availability of the product in emerging nations is anticipated to hamper the growth of Carbapenem Market.
MARKET SCOPE
The "Carbapenem Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Carbapenem Market with detailed market segmentation by type, indications, distribution channel, and geography. The Carbapenem Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Carbapenem Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Carbapenem Market is segmented on the basis by type, indications, and distribution channel. Based on type, the market is segmented into meropenem, doripenem, imipenem tebipenem, and others. Based on indication, the market is segmented into bacterial meningitis, acute pelvic infections, respiratory tract infections, and others. On the basis of distribution channel, the market is segmented into retail pharmacies, online pharmacies, and hospital pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Carbapenem Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Carbapenem Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Carbapenem Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Carbapenem Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Carbapenem Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Carbapenem Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Carbapenem Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Carbapenem Market in these regions.
MARKET PLAYERS
The report covers key developments in the Carbapenem Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Carbapenem Market are anticipated to lucrative growth opportunities in the future with the rising demand for Carbapenem Market in the global market. Below mentioned is the list of few companies engaged in the Carbapenem Market.
The report also includes the profiles of key Carbapenem Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Spero Therapeutics, Inc.
- Savior Lifetec Corporation
- Meiji Seika Pharma Co., Ltd.
- Merck & Co., Inc.
- Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.)
- Aurobindo Pharma Ltd.
- Daewoong Pharmaceutical Co., Ltd.
- Iterum Therapeutics plc
- ACS Dobfar S.p.A.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Carbapenem - By Type
1.3.2 Carbapenem - By Indication
1.3.3 Carbapenem - By Distribution Channel
1.3.4 Carbapenem - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CARBAPENEM LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CARBAPENEM - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CARBAPENEM - GLOBAL MARKET ANALYSIS
6.1. CARBAPENEM - GLOBAL MARKET OVERVIEW
6.2. CARBAPENEM - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CARBAPENEM - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MEROPENEM
7.3.1. Overview
7.3.2. Meropenem Market Forecast and Analysis
7.4. DORIPENEM
7.4.1. Overview
7.4.2. Doripenem Market Forecast and Analysis
7.5. IMIPENEM TEBIPENEM
7.5.1. Overview
7.5.2. Imipenem Tebipenem Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. CARBAPENEM - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. BACTERIAL MENINGITIS
8.3.1. Overview
8.3.2. Bacterial Meningitis Market Forecast and Analysis
8.4. ACUTE PELVIC INFECTIONS
8.4.1. Overview
8.4.2. Acute Pelvic Infections Market Forecast and Analysis
8.5. RESPIRATORY TRACT INFECTIONS
8.5.1. Overview
8.5.2. Respiratory Tract Infections Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. CARBAPENEM - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. HOSPITAL PHARMACIES
9.5.1. Overview
9.5.2. Hospital Pharmacies Market Forecast and Analysis
10. CARBAPENEM REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Carbapenem Overview
10.1.2 North America Carbapenem Forecasts and Analysis
10.1.3 North America Carbapenem Forecasts and Analysis - By Type
10.1.4 North America Carbapenem Forecasts and Analysis - By Indication
10.1.5 North America Carbapenem Forecasts and Analysis - By Distribution Channel
10.1.6 North America Carbapenem Forecasts and Analysis - By Countries
10.1.6.1 United States Carbapenem
10.1.6.1.1 United States Carbapenem by Type
10.1.6.1.2 United States Carbapenem by Indication
10.1.6.1.3 United States Carbapenem by Distribution Channel
10.1.6.2 Canada Carbapenem
10.1.6.2.1 Canada Carbapenem by Type
10.1.6.2.2 Canada Carbapenem by Indication
10.1.6.2.3 Canada Carbapenem by Distribution Channel
10.1.6.3 Mexico Carbapenem
10.1.6.3.1 Mexico Carbapenem by Type
10.1.6.3.2 Mexico Carbapenem by Indication
10.1.6.3.3 Mexico Carbapenem by Distribution Channel
10.2. EUROPE
10.2.1 Europe Carbapenem Overview
10.2.2 Europe Carbapenem Forecasts and Analysis
10.2.3 Europe Carbapenem Forecasts and Analysis - By Type
10.2.4 Europe Carbapenem Forecasts and Analysis - By Indication
10.2.5 Europe Carbapenem Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Carbapenem Forecasts and Analysis - By Countries
10.2.6.1 Germany Carbapenem
10.2.6.1.1 Germany Carbapenem by Type
10.2.6.1.2 Germany Carbapenem by Indication
10.2.6.1.3 Germany Carbapenem by Distribution Channel
10.2.6.2 France Carbapenem
10.2.6.2.1 France Carbapenem by Type
10.2.6.2.2 France Carbapenem by Indication
10.2.6.2.3 France Carbapenem by Distribution Channel
10.2.6.3 Italy Carbapenem
10.2.6.3.1 Italy Carbapenem by Type
10.2.6.3.2 Italy Carbapenem by Indication
10.2.6.3.3 Italy Carbapenem by Distribution Channel
10.2.6.4 Spain Carbapenem
10.2.6.4.1 Spain Carbapenem by Type
10.2.6.4.2 Spain Carbapenem by Indication
10.2.6.4.3 Spain Carbapenem by Distribution Channel
10.2.6.5 United Kingdom Carbapenem
10.2.6.5.1 United Kingdom Carbapenem by Type
10.2.6.5.2 United Kingdom Carbapenem by Indication
10.2.6.5.3 United Kingdom Carbapenem by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Carbapenem Overview
10.3.2 Asia-Pacific Carbapenem Forecasts and Analysis
10.3.3 Asia-Pacific Carbapenem Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Carbapenem Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Carbapenem Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Carbapenem Forecasts and Analysis - By Countries
10.3.6.1 Australia Carbapenem
10.3.6.1.1 Australia Carbapenem by Type
10.3.6.1.2 Australia Carbapenem by Indication
10.3.6.1.3 Australia Carbapenem by Distribution Channel
10.3.6.2 China Carbapenem
10.3.6.2.1 China Carbapenem by Type
10.3.6.2.2 China Carbapenem by Indication
10.3.6.2.3 China Carbapenem by Distribution Channel
10.3.6.3 India Carbapenem
10.3.6.3.1 India Carbapenem by Type
10.3.6.3.2 India Carbapenem by Indication
10.3.6.3.3 India Carbapenem by Distribution Channel
10.3.6.4 Japan Carbapenem
10.3.6.4.1 Japan Carbapenem by Type
10.3.6.4.2 Japan Carbapenem by Indication
10.3.6.4.3 Japan Carbapenem by Distribution Channel
10.3.6.5 South Korea Carbapenem
10.3.6.5.1 South Korea Carbapenem by Type
10.3.6.5.2 South Korea Carbapenem by Indication
10.3.6.5.3 South Korea Carbapenem by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Carbapenem Overview
10.4.2 Middle East and Africa Carbapenem Forecasts and Analysis
10.4.3 Middle East and Africa Carbapenem Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Carbapenem Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Carbapenem Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Carbapenem Forecasts and Analysis - By Countries
10.4.6.1 South Africa Carbapenem
10.4.6.1.1 South Africa Carbapenem by Type
10.4.6.1.2 South Africa Carbapenem by Indication
10.4.6.1.3 South Africa Carbapenem by Distribution Channel
10.4.6.2 Saudi Arabia Carbapenem
10.4.6.2.1 Saudi Arabia Carbapenem by Type
10.4.6.2.2 Saudi Arabia Carbapenem by Indication
10.4.6.2.3 Saudi Arabia Carbapenem by Distribution Channel
10.4.6.3 U.A.E Carbapenem
10.4.6.3.1 U.A.E Carbapenem by Type
10.4.6.3.2 U.A.E Carbapenem by Indication
10.4.6.3.3 U.A.E Carbapenem by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Carbapenem Overview
10.5.2 South and Central America Carbapenem Forecasts and Analysis
10.5.3 South and Central America Carbapenem Forecasts and Analysis - By Type
10.5.4 South and Central America Carbapenem Forecasts and Analysis - By Indication
10.5.5 South and Central America Carbapenem Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Carbapenem Forecasts and Analysis - By Countries
10.5.6.1 Brazil Carbapenem
10.5.6.1.1 Brazil Carbapenem by Type
10.5.6.1.2 Brazil Carbapenem by Indication
10.5.6.1.3 Brazil Carbapenem by Distribution Channel
10.5.6.2 Argentina Carbapenem
10.5.6.2.1 Argentina Carbapenem by Type
10.5.6.2.2 Argentina Carbapenem by Indication
10.5.6.2.3 Argentina Carbapenem by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CARBAPENEM, KEY COMPANY PROFILES
12.1. SPERO THERAPEUTICS, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SAVIOR LIFETEC CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MEIJI SEIKA PHARMA CO., LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK AND CO., INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GLAND PHARMA LTD. (FOSUN PHARMACEUTICAL CO., LTD.)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. AUROBINDO PHARMA LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DAEWOONG PHARMACEUTICAL CO., LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ITERUM THERAPEUTICS PLC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ACS DOBFAR S.P.A.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Spero Therapeutics, Inc.
2. Savior Lifetec Corporation
3. Meiji Seika Pharma Co., Ltd.
4. Merck & Co., Inc.
5. Gland Pharma Ltd. (Fosun Pharmaceutical Co., Ltd.)
6. Aurobindo Pharma Ltd.
7. Daewoong Pharmaceutical Co., Ltd.
8. Iterum Therapeutics plc
9. ACS Dobfar S.p.A.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For